iSpecimen (ISPC) EBT Margin Growth (1y) (2021 - 2026)
iSpecimen (ISPC) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -37.00 |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 | -152,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -152,852.00 |
| Dec 31, 2025 | -512,107.00 |
| Sep 30, 2025 | -259,062.00 |
| Jun 30, 2025 | -20,132.00 |
| Mar 31, 2025 | -2,384.00 |
| Dec 31, 2024 | -30,438.00 |
| Sep 30, 2024 | 2,109.00 |
| Jun 30, 2024 | 12,476.00 |
| Mar 31, 2024 | -5,694.00 |
| Dec 31, 2023 | -5,268.00 |
| Sep 30, 2023 | 4,135.00 |
| Jun 30, 2023 | -11,200.00 |
| Mar 31, 2023 | 2,232.00 |
| Dec 31, 2022 | 766.00 |
| Sep 30, 2022 | -6,960.00 |
| Jun 30, 2022 | -6,704.00 |
| Mar 31, 2022 | -5,241.00 |
| Dec 31, 2021 | -2,228.00 |
| Sep 30, 2021 | -173.00 |
| Jun 30, 2021 | -3,646.00 |